Literature DB >> 19855423

Dialysis: Intradermal HBV vaccination is preferable in non-responders.

Adeera Levin.   

Abstract

In patients on hemodialysis with a history of failure to respond to hepatitis B vaccination, intradermal revaccination is more effective than repeat intramuscular vaccination. Intradermal vaccine administration might become the standard of care for high-risk patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19855423     DOI： 10.1038/nrneph.2009.166

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  8 in total

1.  Serum antibody responses after intradermal vaccination against influenza.

Authors:  Robert B Belshe; Frances K Newman; Joan Cannon; Carol Duane; John Treanor; Christian Van Hoecke; Barbara J Howe; Gary Dubin
Journal:  N Engl J Med       Date:  2004-11-03       Impact factor: 91.245

Review 2.  Influence of uraemia and haemodialysis on host defence and infection.

Authors:  R Vanholder; A Van Loo; A M Dhondt; R De Smet; S Ringoir
Journal:  Nephrol Dial Transplant       Date:  1996-04       Impact factor: 5.992

3.  Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

Authors:  S Caillat-Zucman; J J Gimenez; F Wambergue; G Albouze; B Lebkiri; C Naret; A Moynot; P Jungers; J F Bach
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

Review 4.  Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.

Authors:  F Fabrizi; V Dixit; M Magnini; A Elli; P Martin
Journal:  Aliment Pharmacol Ther       Date:  2006-08-01       Impact factor: 8.171

5.  Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.

Authors:  Olivier Mat; Fabienne Mestrez; Renaud Beauwens; Marie-Carmen Muniz-Martinez; Michel Dhaene
Journal:  Hemodial Int       Date:  2006-01       Impact factor: 1.812

6.  Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.

Authors:  Mansur Kayataş
Journal:  Artif Organs       Date:  2002-06       Impact factor: 3.094

7.  Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination.

Authors:  T Propst; A Propst; K Lhotta; W Vogel; P König
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

8.  Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.

Authors:  Katherine A Barraclough; Kathryn J Wiggins; Carmel M Hawley; Carolyn L van Eps; David W Mudge; David W Johnson; Michael Whitby; Sally Carpenter; E Geoffrey Playford
Journal:  Am J Kidney Dis       Date:  2009-05-29       Impact factor: 8.860
  8 in total
  3 in total

1.  Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.

Authors:  Salvatore Leonardi; Andrea Domenico Praticò; Elena Lionetti; Massimo Spina; Giovanna Vitaliti; Mario La Rosa
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

2.  Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients.

Authors:  Mohammad H Ghadiani; Shahin Besharati; Nouraddin Mousavinasab; Mojgan Jalalzadeh
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

3.  Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control study.

Authors:  Simin Wen; Yanhua Wu; Yuchen Pan; Mengzhuo Cao; Dan Zhao; Chong Wang; Chuan Wang; Fei Kong; Jie Li; Junqi Niu; Jing Jiang
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.